Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review.
Proceedings of the European Charcot Foundation Symposium A Reappraisal of Nutrition and Environment in Multiple Sclerosis, European Charcot Foundation Symposium, December 2-4, 2010, Fiuggi, Italy.
Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation.
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function.
Vitamin D and multiple sclerosis: where do we go from here?
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
Axoskeletal proteins prevent oligodendrocyte from toxic injury by upregulating survival, proliferation, and differentiation in vitro.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Secukinumab: first global approval.
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Compressive myelopathy: magnetic resonance imaging findings simulating idiopathic acute transverse myelopathy.
Multiple sclerosis: Five new things.
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis.

Pages